SEKISUI Diagnostics
Keith S. has a diverse work experience in the field of clinical affairs and research. Keith has held various managerial positions and played a vital role in companies like SEKISUI Diagnostics, Pfizer Laboratories, Lucira Health, DiaSorin Molecular LLC, DiaSorin, National Center for Competency Testing (NCCT), Focus Diagnostics, and Quest Diagnostics. Keith'sexpertise ranges from being a director of clinical research and clinical affairs to a subject matter expert and clinical research associate. Keith's experience spans over many years, starting from 2007 to their current position as a Director of Clinical Research at SEKISUI Diagnostics.
Keith S. graduated in 2001 with a Bachelor of Science degree in Biological Science from California State University, Fullerton. Keith later obtained a certification as a Certified Phlebotomy Technician (CPT I) in Phlebotomy Technician/Phlebotomist from U.S. Colleges in 2012.
Additionally, Keith S. has obtained several certifications in recent years. In March 2021, they completed certifications in "Communicating about Culturally Sensitive Issues," "Diversity, Inclusion, and Belonging," and "Unconscious Bias" from LinkedIn.
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals